Cepheid Shares Up 8.4 Percent on Anthrax Detection News | GenomeWeb

NEW YORK, Feb. 16 (GenomeWeb News) - Shares of Cepheid were up $.80, or 8.41 percent, at $10.31 in afternoon trading after the company this morning said that its GeneXpert real-time PCR platform for mobile anthrax detection had been licensed by biothreat agencies in Oakland, Mich., and Honolulu, Hawaii.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.